Here’s how the Northeast could get its first snow of the season next week




Cheap antidepressant shows promise; virus can infect inner ear

Fluvoxamine, an inexpensive antidepressant, might help keep patients with COVID-19 from developing severe disease, according to a new study published in The Lancet Global Health on Wednesday. Researchers in Brazil recruited nearly 1,500 COVID-19 patients at high risk for complications and randomly assigned half of them to receive fluvoxamine by mouth for 10 days. Over the next month, 11% of the fluvoxamine group needed at least six hours of emergency care or were hospitalized, compared to 16% of patients who did not get fluvoxamine, and fewer fluvoxamine patients died, the researchers.


Source link